{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:56:25Z","timestamp":1784868985874,"version":"3.55.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic hepatitis B (CHB) remains a global health challenge, with current therapies achieving low rates of functional cure (FC). Reliable biomarkers are urgently needed to guide individualized treatment. This study characterized the immune\u2013metabolic profiles of CHB patients receiving pegylated interferon-\u03b1 (PegIFN-\u03b1) or nucleos(t)ide analogues (NAs), focusing on mitochondrial function as a novel predictor of therapeutic response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 93 CHB patients and 32 healthy controls were recruited from three centers. Peripheral blood leukocyte subsets and mitochondrial parameters, including mitochondrial mass (MM) and the percentage of cells with low mitochondrial membrane potential (MMPlow%), were assessed by flow cytometry. Multivariate logistic regression and receiver operating characteristic (ROC) analyses were used to identify independent predictors and evaluate biomarker performance for FC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Untreated CHB patients showed marked mitochondrial depletion across immune subsets. NA therapy normalized mitochondrial parameters without improving FC rates, whereas PegIFN-\u03b1 therapy selectively remodeled CD4+ T cell metabolism and promoted monocyte differentiation. Improved mitochondrial efficiency in CD8+ T cells and elevated monocyte counts were closely associated with HBsAg clearance. Lymphocyte MMPlow% showed the strongest individual predictive value, while an integrated immune\u2013metabolic model further enhanced accuracy for FC prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Immune\u2013metabolic remodeling underlies PegIFN-\u03b1\u2013induced functional cure in CHB. Mitochondrial profiling provides a promising framework for precision stratification and immune-based therapeutic optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2025.1719456","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:40:33Z","timestamp":1768372833000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Mitochondrial metabolic remodeling predicts therapeutic response to PegIFN-\u03b1 in chronic hepatitis B"],"prefix":"10.3389","volume":"15","author":[{"given":"Yingying","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu","family":"Han","sequence":"additional","affiliation":[{"name":"Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Xu","sequence":"additional","affiliation":[{"name":"Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Song","sequence":"additional","affiliation":[{"name":"Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoran","family":"Zhou","sequence":"additional","affiliation":[{"name":"Medical College of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical College of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchi","family":"Xu","sequence":"additional","affiliation":[{"name":"Center of Clinical Laboratory, The Fifth People\u2019s Hospital of Suzhou","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Wu","sequence":"additional","affiliation":[{"name":"Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhen","family":"Han","sequence":"additional","affiliation":[{"name":"Center of Clinical Laboratory and Translational Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zutao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial dynamics controls T cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat. Med."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3350\/cmh.2022.0420","article-title":"Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm","volume":"29","author":"Hsu","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1476-4598-10-43","article-title":"HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascade","volume":"10","author":"Hu","year":"2011","journal-title":"Mol. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/HEP.0000000000000524","article-title":"Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-\u03b1 in patients with chronic hepatitis B","volume":"79","author":"Jiang","year":"2024","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s12072-024-10648-8","article-title":"Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-\u03b1: a systematic review and meta-analysis","volume":"18","author":"Jiang","year":"2024","journal-title":"Hepatol. Int."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003722","article-title":"Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis","volume":"9","author":"Kim","year":"2013","journal-title":"PloS Pathog."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/v15122359","article-title":"Regulation of mitochondrial metabolism by hepatitis B virus","volume":"15","author":"Li","year":"2023","journal-title":"Viruses"},{"key":"B14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2023-330389","article-title":"Novel function of MOTS-c in mitochondrial remodelling contributes to its antiviral role during HBV infection","volume":"73","author":"Lin","year":"2024","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/hep.30474","article-title":"The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among asian patients with chronic hepatitis B: A systematic review","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"21008","DOI":"10.1038\/s41598-025-05922-0","article-title":"Mitochondria-related parameters of lymphocyte subsets can distinguish different disease stages in patients with HBV infection","volume":"15","author":"Liu","year":"2025","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1477646","article-title":"Altered mitochondrial mass and low mitochondrial membrane potential of immune cells in patients with HBV infection and correlation with liver inflammation","volume":"15","author":"Ma","year":"2024","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial dysfunction and signaling in chronic liver diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/infdis\/jiaa064","article-title":"IFN-\u03b1 Suppresses myeloid cytokine production, impairing IL-12 production and the ability to support T-cell proliferation","volume":"222","author":"Mehrotra","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3748\/wjg.v13.i14.2104","article-title":"Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B","volume":"13","author":"Shao","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.scib.2024.04.014","article-title":"Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression","volume":"69","author":"Su","year":"2024","journal-title":"Sci. Bull. (Beijing)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","article-title":"Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development","volume":"73","author":"Tout","year":"2020","journal-title":"J. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3350\/cmh.2023.0194","article-title":"Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation","volume":"30","author":"Tsai","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1053\/j.gastro.2023.01.005","article-title":"Low hepatitis B core-related antigen levels correlate higher spontaneous seroclearance of hepatitis B surface antigen in chronic hepatitis B patients with high hepatitis B surface antigen levels","volume":"164","author":"Tseng","year":"2023","journal-title":"Gastroenterology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.immuni.2011.12.007","article-title":"Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development","volume":"36","author":"van der Windt","year":"2012","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2404965","DOI":"10.1080\/21505594.2024.2404965","article-title":"Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B","volume":"15","author":"Wang","year":"2024","journal-title":"Virulence"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1136\/gutjnl-2022-328734","article-title":"Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8(+) T cells","volume":"72","author":"Winkler","year":"2023","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.dld.2019.02.009","article-title":"Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study","volume":"51","author":"Xu","year":"2019","journal-title":"Dig Liver Dis."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.3748\/wjg.v28.i40.5784","article-title":"Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-\u03b1 treatment and retreatment","volume":"28","author":"Yin","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.14218\/JCTH.2023.00320","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)","volume":"3","author":"You","year":"2023","journal-title":"Infect. Dis. Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"105782","DOI":"10.1016\/j.antiviral.2023.105782","article-title":"Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy","volume":"221","author":"Zhao","year":"2024","journal-title":"Antiviral Res."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18440","article-title":"Altered counts and mitochondrial mass of peripheral blood leucocytes in patients with chronic hepatitis B virus infection","volume":"28","author":"Zhou","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2004.07.003","article-title":"Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection","volume":"64","author":"Zoulim","year":"2004","journal-title":"Antiviral Res."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1719456\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:39:29Z","timestamp":1771911569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1719456\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":36,"alternative-id":["10.3389\/fcimb.2025.1719456"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1719456","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1719456"}}